mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.01 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |